First Bight Ventures

Founder and Managing Partner Veronica Breckenridge leads all investment decisions. She is supported by Principal Jonathan Mercado, PhD, who handles day-to-day deal execution. The firm's four-person team operates from Houston, Texas, with a formal network of advisors from McKinsey, Novozymes, and Cargill providing technical and commercial diligence.

First Bight sources through a proprietary biomanufacturing ecosystem that connects large industrial corporations, government agencies, universities, and foundations. The firm's advisors — including former McKinsey Global Energy & Materials practice lead Scott Nyquist and Novozymes ventures lead Mario Maia — provide direct lines into corporate R&D pipelines. Breckenridge's operational background at Tesla and Apple also feeds a network of technical founders.

First Bight invests directly into companies, leading and writing first checks from seed through Series A. There is no indication the firm makes fund-of-fund commitments or participates in club deals as a limited partner. Its model requires board seats and active operational involvement in every portfolio company.

The firm invests at what it calls the pilot-to-commercialization inflection point — after proof of concept but before full commercial scale. It explicitly finances engineering risk (scaling a proven process) and avoids market risk and technical risk. Checks span seed to Series A rounds, with a pathway for portfolio companies to reach $100 million-plus in annual revenue.

First Bight avoids any sector outside biomanufacturing and sustainable chemistry. Within that domain, it will not finance companies still carrying fundamental technical risk or those targeting markets too small to support a billion-dollar exit. The firm requires a visible path to cost parity with incumbent petroleum-based products and a minimum 20x return potential.

First Bight maintains a deliberate ecosystem approach that brings corporate venture arms and strategic partners into its deals. Advisor Mario Maia's background leading Novozymes' corporate venturing arm suggests the firm actively structures co-investment opportunities with industrial strategics. However, as a lead investor that takes board seats, First Bight does not operate as a passive co-investor itself.

There is no publicly disclosed philanthropic foundation tied to First Bight Ventures. The firm's website lists foundations as one of six stakeholder groups in its biomanufacturing ecosystem — alongside investors, corporations, startups, governments, and universities — but does not detail any separate charitable vehicle.